ArticleTherapeutic advances in medical oncology2025
Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients.
Xiaomeng Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it